Abstract
Enzyme inhibitors are important tools of nature for regulating the activity of enzymes in case of emergency. Proteinaceous inhibitors are the best studied in this group. Comparatively less is known about the inhibitors of α-amylase, which might be an attractive candidate having potentials in various fields, from the treatment of diabetes to crop protection. The area has benefited from the recent determination of structures of α-amylases, inhibitors and complexes. Besides, discussing various types of α-amylase inhibitors and their structural basis of inhibition, the biotechnological approaches for exploitation of its inhibitory function have been outlined in this minireview.
Keywords: Amylase, inhibitor, acarbose, starch, diabetes, Proteinaceous inhibitors, α-amylase, phytopathogenic microorganisms, transgenic plants, Eleusine coracana, porcine pancreas (PPA), Streptomyces, Sorghum, Trichoderma resei, 3-D structure, hyperglycemia, acarviosine-glucose, α-amylase inhibitor, Apostolidis, γ-purothionin, thaumatin, Tribolium castaneum, bruchids, pig pancreatic α-amylase, Ragi bifunctional inhibitor, sorghum inhibitor, Ragi α-amylase/trypsin inhibitor, Barley α-amylase/subtilisin inhibitor
Current Enzyme Inhibition
Title: α-Amylase Inhibition: Some Practical Considerations
Volume: 6 Issue: 3
Author(s): Om Prakash and Nivedita Jaiswal
Affiliation:
Keywords: Amylase, inhibitor, acarbose, starch, diabetes, Proteinaceous inhibitors, α-amylase, phytopathogenic microorganisms, transgenic plants, Eleusine coracana, porcine pancreas (PPA), Streptomyces, Sorghum, Trichoderma resei, 3-D structure, hyperglycemia, acarviosine-glucose, α-amylase inhibitor, Apostolidis, γ-purothionin, thaumatin, Tribolium castaneum, bruchids, pig pancreatic α-amylase, Ragi bifunctional inhibitor, sorghum inhibitor, Ragi α-amylase/trypsin inhibitor, Barley α-amylase/subtilisin inhibitor
Abstract: Enzyme inhibitors are important tools of nature for regulating the activity of enzymes in case of emergency. Proteinaceous inhibitors are the best studied in this group. Comparatively less is known about the inhibitors of α-amylase, which might be an attractive candidate having potentials in various fields, from the treatment of diabetes to crop protection. The area has benefited from the recent determination of structures of α-amylases, inhibitors and complexes. Besides, discussing various types of α-amylase inhibitors and their structural basis of inhibition, the biotechnological approaches for exploitation of its inhibitory function have been outlined in this minireview.
Export Options
About this article
Cite this article as:
Prakash Om and Jaiswal Nivedita, α-Amylase Inhibition: Some Practical Considerations, Current Enzyme Inhibition 2010; 6 (3) . https://dx.doi.org/10.2174/157340810793384089
DOI https://dx.doi.org/10.2174/157340810793384089 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Acute Severe Colitis: Infliximab and/or Cyclosporine?
Current Drug Targets Prospects of Molecularly-Targeted Therapies for Cervical Cancer Treatment
Current Drug Targets Interindividual Variability in the Efficacy of Oral Antiplatelet Drugs: Definitions, Mechanisms and Clinical Importance
Current Pharmaceutical Design Growth Hormone Secretagogue (Ghrelin-) Receptors - A Complex Drug Target for the Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets Dexamethasone and Restenosis After Coronary Stent Implantation: New Indication for an Old Drug?
Current Pharmaceutical Design Current Pharmacological Approach to Restore Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry Diabetes Exacerbates Nanoparticles Induced Brain Pathology
CNS & Neurological Disorders - Drug Targets Neuroprotection by Resveratrol in Diabetic Neuropathy: Concepts & Mechanisms
Current Medicinal Chemistry Which are the Best Follow-Up Strategies for Patients Who Undergo Percutaneous Coronary Interventions?
Current Cardiology Reviews Multiple Roles of Fibroblast Growth Factor 21 in Metabolism
Current Pharmaceutical Design Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy Mitochondria in Chronic Liver Disease
Current Drug Targets Editorial (Thematic Issue: Cognitive Dysfunction in Major Depressive Disorder - Pathophysiology, Clinical Implications and Treatment Opportunities)
CNS & Neurological Disorders - Drug Targets Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints
Current Pharmaceutical Design Autoimmune Pancreatitis and Diagnostic Criteria
Current Immunology Reviews (Discontinued) Immune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised
Current Pharmaceutical Design Regulation and Quantification of Cellular Mitochondrial Morphology and Content
Current Pharmaceutical Design Platelet Activation in Alzheimer’s Disease: From Pathophysiology to Clinical Value
Current Vascular Pharmacology Vitamin D3, D2 and Arterial Wall Properties in Coronary Artery Disease
Current Pharmaceutical Design Determinants of Use of Long-term Continuous Electrocardiographic Monitoring for Acute Ischemic Stroke Patients without Atrial Fibrillation at Baseline
Current Neurovascular Research